These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39403723)
1. CKAP2 Regulated by TFDP1 Promotes Metastasis and Proliferation of Colorectal Cancer through Affecting the Tumor Microenvironment. Zhong Z; Cheng S; Liu Y J Microbiol Biotechnol; 2024 Nov; 34(11):2211-2222. PubMed ID: 39403723 [TBL] [Abstract][Full Text] [Related]
2. The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasis. Mei H; Luo Q; Weng J; Hao J; Cai J; Zhou R; Bian C; Ye Y; Luo S; Wen Y Cell Mol Biol Lett; 2024 Nov; 29(1):144. PubMed ID: 39587482 [TBL] [Abstract][Full Text] [Related]
3. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p. Yi J; Ye Z; Xu H; Zhang H; Cao H; Li X; Wang T; Dong C; Du Y; Dong S; Zhou W Phytomedicine; 2024 Dec; 135():156137. PubMed ID: 39566403 [TBL] [Abstract][Full Text] [Related]
4. Reduced Proline-Rich Tyrosine Kinase 2 Promotes Tumor Metastasis by Activating Epithelial-Mesenchymal Transition in Colorectal Cancer. Wu F; Zhang K; Song Z; Zhou Q; Sun H; Tan Z; Huang Z; Wang F; Wang Z; Yang R; Huang Y Dig Dis Sci; 2024 Nov; 69(11):4098-4107. PubMed ID: 39414740 [TBL] [Abstract][Full Text] [Related]
5. TFDP1 transcriptionally activates KIF22 to enhance aggressiveness and stemness in endometrial cancer: implications for prognosis and targeted therapy. Lai L; Miao Q J Mol Histol; 2024 Dec; 56(1):40. PubMed ID: 39672972 [TBL] [Abstract][Full Text] [Related]
6. Macrophage Migration Inhibitory Factor (MIF) Upregulates CXCR7 and Contributes to Chemotherapy Resistance in Colorectal Cancer. Hu S; Feng J; Fu W; Guo Y Cell Biochem Biophys; 2024 Dec; 82(4):3437-3452. PubMed ID: 39018005 [TBL] [Abstract][Full Text] [Related]
7. Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors. Haoyue W; Kexiang S; Shan TW; Jiamin G; Luyun Y; Junkai W; Wanli D Phytomedicine; 2024 Nov; 136():156224. PubMed ID: 39642461 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA AC105118.1 affects glycolysis to facilitate oxaliplatin resistance in colorectal cancer cells by modulating the miR-378a-3p/KIF26B axis. Zhang Y; Shen Z; Han X; Wu Y; Huang T Int J Biochem Cell Biol; 2024 Dec; 177():106692. PubMed ID: 39536859 [TBL] [Abstract][Full Text] [Related]
9. SULT2B1: a novel therapeutic target in colorectal cancer via modulation of AKT/PKM2-mediated glycolysis and proliferation. Ma J; Sun F; Li W; Du R; Liu M; Wei Q; Kang B; Yan S; Wang C J Transl Med; 2024 Dec; 22(1):1093. PubMed ID: 39623433 [TBL] [Abstract][Full Text] [Related]
10. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
11. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
12. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
13. Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in Ghosh S; Fan F; Powell R; Park YS; Stephan C; Kopetz ES; Ellis LM; Bhattacharya R Ther Adv Med Oncol; 2024; 16():17588359241303302. PubMed ID: 39664300 [TBL] [Abstract][Full Text] [Related]
14. The new anti-angiogenesis perspective of rheumatoid arthritis with geniposide: Reducing the extracellular release of HSP70 in HUVECs. Wei Y; Li Y; Shu Y; Gan PR; Zhu YL; Xu J; Jiang XM; Xia SL; Wang Y; Wu H Int Immunopharmacol; 2025 Jan; 144():113645. PubMed ID: 39571270 [TBL] [Abstract][Full Text] [Related]
15. PFAS promotes colorectal cancer progression via regulating RIG-I-mediated innate immune signalling. Ding C; Tao G; Chen G; Xie Y; Yang C; Qi S; Hou J; Jiang X; Deng X; Liao W Mol Immunol; 2024 Dec; 176():73-83. PubMed ID: 39586166 [TBL] [Abstract][Full Text] [Related]
16. Euphorbia Pekinensis Rupr. sensitizes colorectal cancer to PD-1 blockade by remodeling the tumor microenvironment and enhancing peripheral immunity. Chen YY; Zeng XT; Gong ZC; Zhang MM; Wang KQ; Tang YP; Huang ZH Phytomedicine; 2024 Dec; 135():156107. PubMed ID: 39368338 [TBL] [Abstract][Full Text] [Related]
17. METTL3-VISTA axis-based combination immunotherapy for APC truncation colorectal cancer. Wu L; Bai R; Zhang Y; Chen H; Wu J; Chen Z; Wang H; Zhao L J Immunother Cancer; 2024 Dec; 12(12):. PubMed ID: 39653551 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of colorectal cancer aggressiveness by Oleanolic acid through Nur77 degradation. Deng S; Liu Y; Liu X; Yu J; Chen Y; Huo J Phytomedicine; 2024 Dec; 135():156192. PubMed ID: 39520953 [TBL] [Abstract][Full Text] [Related]
19. CELF6 as an Oncogene in Colorectal Cancer: Targeting Stem-Cell-Like Properties Through Modulation of Fu Z; Wang X; Chen Z; Wang B; Huang W; Liu X Front Biosci (Landmark Ed); 2024 Nov; 29(11):395. PubMed ID: 39614437 [TBL] [Abstract][Full Text] [Related]